ArticleAnnals of Indian Academy of Neurology2026

Effectiveness and Safety of Cladribine in Relapsing-Remitting Multiple Sclerosis in Clinical Practice: A 2-Year Multicenter Retrospective Open-Label Study.

M Susana Fortes-González et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.